
|Articles|December 1, 2002
CMV retinitis treatment responding to changing HIV therapy
Editor's Note: HIV/AIDS continues to be a major health problem, not only in the developing world, but in North America and Europe as well. Although the incidence of ocular complications of HIV/AIDS has decreased dramatically since the introduction of highly active anti-retroviral therapy (HAART), the prevalence of HIV positivity continues toincrease, particularly among heterosexual women and minorities.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025 Takeaways: A new biomechanical paradigm for presbyopia
2
AAO 2025 Takeaways: The new era of glaucoma treatment and surgical precision
3
AAO 2025 Takeaways: Cornea, refractive surgery, and aesthetics redefined
4
Managing Unique Dry Eye Disease Subtypes in Patients
5

















































.png)


